Why to attend ISCO 25?

Attending ISCO 25, the annual congress organized by the International School of Clinical Oncology (ISCO), offers several valuable benefits for oncologists and professionals in the field:

1. Knowledge and Education: ISCO 25 provides a platform for oncologists to expand their knowledge and stay updated with the latest advancements in clinical oncology. The congress features eminent speakers from all around the globe who present the most up-to-date data on clinical trials, research findings, and cancer management.

2. Networking and Collaboration: ISCO 25 brings together oncologists and professionals from various countries and institutions, creating a conducive environment for networking and collaboration.

3. Exposure to New Clinical Programs: The congress promotes the exchange of clinical programs, allowing attendees to learn about innovative approaches and practices being implemented in different regions.

4. Access to Cutting-Edge Research: ISCO 25 provides updates on the latest research in clinical trials and progress against cancer.

5. Professional Development: ISCO 25 is a continuous medical and clinical education platform. The knowledge acquired at ISCO 25 can be applied to improve patient care, decision-making, and overall practice in oncology.

About The ISCO

The International School of Clinical Oncology (ISCO) is an esteemed institution that aims to recognize and highlight the significant contributions of expert oncologists around the world. Throughout the years, ISCO had formed a renowned international faculty of experts in the field on oncology that, through their contribution to clinical research, practice, and continuous education, decided to foster a global community of knowledge for their fellow international colleagues.

Accordingly, the ISCO faculty, to showcase the dedication to education and innovation, organizes an annual congress that brings together oncologists from around the world to exhibit the school’s activities and provide education on the latest updates in clinical trials and progress towards cancer research and change of practice.

ISCO’s mission revolves around upholding equality in education by ensuring that all oncologists have access to the same level of knowledge, understanding, and awareness of the latest updates
and advancements in the field.
The faculty achieves the means through various initiatives, including monthly educational meetings where experts from around the world present the most up-to-date data.

Continuous scientific exchange of data and clinical education is a cornerstone of ISCO’s philosophy. We recognize the importance of staying abreast of evolving practices and advancements in oncology, and actively promote learning opportunities for oncologists. For that, ISCO also sponsors the exchange of clinical programs, allowing oncologists to share best practices, experiences, and expertise with their peers globally. By facilitating such exchanges, ISCO aims to foster a collaborative environment where knowledge can be shared and disseminated effectively.